Answers are grounded in this paper and cite their sources.
Case report reveals systemic anaphylaxis following prolonged allergen immunotherapy, suggesting the need for ongoing patient monitoring.
This case report documents a rare phenomenon of a serious systemic allergic reaction following nearly five years of ongoing allergen immunotherapy (AIT) in a 19-year-old male patient. The patient, stable on maintenance AIT for sensitization to dust mite, cat dander, and birch pollen, developed acute respiratory distress minutes after a routine injection. Emergency treatment with epinephrine, diphenhydramine, and salbutamol was successful. This case highlights several potential causes, including loss of immune tolerance, immune deviation due to infection, and possible immunomodulating properties of concurrent fluoxetine treatment. It is a reminder that patients on long-term AIT need to continue on follow-up and that drug-AIT interactions are an area for ongoing investigation.
No takes yet. Share an insight, caveat, or question.
Ehsani et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: